Comment on: Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications?
Michael R
MR
Backhouse
Philip S
PS
Helliwell
Anthony C
AC
Redmond
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000601:surgery*; D006801:Humans; D007596:Joints / Q000601:surgery; D009894:Opportunistic Infections / Q000139:chemically induced; D019990:Perioperative Care / Q000379:methods; D011183:Postoperative Complications; D012307:Risk Factors; D013530:Surgical Wound Infection; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha